Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA HERPES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 VIRUS TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SUMMARY WRITE UP (NORTH AMERICA)
4.1.1 OVERVIEW
4.2 SUMMARY WRITE UP (EUROPE)
4.2.1 OVERVIEW
4.3 SUMMARY WRITE UP (ASIA-PACIFIC)
4.3.1 OVERVIEW
4.4 SUMMARY WRITE UP (SOUTH AMERICA)
4.4.1 OVERVIEW
4.5 SUMMARY WRITE UP (MIDDLE EAST AND AFRICA)
4.5.1 OVERVIEW
5 MIDDLE EAST AND AFRICA HERPES MARKET: REGULATIONS
5.1 THE U.S. REGULATORY FRAMEWORK
5.2 CANADA REGULATORY FRAMEWORK
5.3 THE EUROPE REGULATORY FRAMEWORK
5.4 INDIA REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.2 INCREASING GERIATRIC POPULATION
6.2.1 INCREASE IN PREVALENCE OF HERPES INFECTIONS
6.2.2 INCREASE IN NUMBER OF PRODUCT APPROVALS AND LAUNCHES
6.2.3 RISING NUMBER OF IMMUNOCOMPROMISED PEOPLE
6.3 RESTRAINTS
6.3.1 HIGH COST OF ANTI-HERPETIC MEDICINES
6.3.2 PRODUCT RECALL
6.4 OPPORTUNITIES
6.4.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.4.2 INCREASING HEALTHCARE EXPENDITURE
6.4.3 SOARING NUMBER OF ANTI-HERPETIC DRUGS MANUFACTURERS
6.4.4 RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (CRO)
6.5 CHALLENGES
6.5.1 DISRUPTION IN THE SUPPLY CHAIN OF HERPES DRUGS AND INJECTIONS DURING COVID-19
6.5.2 LACK OF WORKFORCE IN PHARMA INDUSTRIES
7 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA HERPES MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISION BY MANUFACTURERS
7.5 CONCLUSION
8 MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE
8.1 OVERVIEW
8.2 HERPES SIMPLEX
8.2.1 TYPE I
8.2.2 TYPE II
8.3 HERPES ZOSTER
9 MIDDLE EAST AND AFRICA HERPES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 ACYCLOVIR
9.3 DOCOSANOL
9.4 VALACYCLOVIR
9.5 FAMCICLOVIR
9.6 OTHERS
10 MIDDLE EAST AND AFRICA HERPES MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 PRESCRIPTION DRUG
10.3 OVER-THE COUNTER DRUG
11 MIDDLE EAST AND AFRICA HERPES MARKET, BY AGE
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 MIDDLE EAST AND AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 TOPICAL
12.3 ORAL
12.4 PARENTERAL
13 MIDDLE EAST AND AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 HOSPITALS PHARMACIES
13.3 RETAIL PHARMACIES
13.4 DRUG STORES
13.5 ONLINE PHARMACIES
13.6 OTHERS
14 MIDDLE EAST AND AFRICA HERPES MARKET, BY END USERS
14.1 OVERVIEW
14.2 HOSPITALS
14.3 SPECIALITY CLINICS
14.4 OTHERS
15 MIDDLE EAST AND AFRICA HERPES MARKET, BY REGION
15.1 MIDDLE EAST AND AFRICA
15.1.1 SOUTH AFRICA
15.1.2 SAUDI ARABIA
15.1.3 U.A.E.
15.1.4 EGYPT
15.1.5 ISRAEL
15.1.6 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST AND AFRICA HERPES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GLAXOSMITHKILNE PLC
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENT
18.2 VIATRIS INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENT
18.3 FRESENIUS KABI AG
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 PFIZER INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 ABBOTT
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 AMNEAL PHARMACEUTICALS LLC
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 APOTEX INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENT
18.1 AVET PHARMACEUTICALS INC.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 BAUSCH HEALTH COMPANIES INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 BLISTEX, INC.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 CIPLA, INC.
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 DR. REDDY’S LABORATORIES LTD.
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENT
18.15 EPIHEALTH
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 GLENMARK PHARMACEUTICAL INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICALS LTD.)
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 PRODUCT PORTFOLIO
18.16.4 RECENT DEVELOPMENT
18.17 MARUHO CO.,LTD.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 RECORDATI S.P.A.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SLAVIA PHARM S.R.L.
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 SUN PHARMACEUTICAL INDUSTRIES LTD
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENT
18.21 ZYDUS PHARMACEUTICALS, INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 THE EMA HAS SEVEN SCIENTIFIC COMMITTEES THAT CARRY OUT ITS SCIENTIFIC ASSESSMENTS:
TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS
TABLE 4 MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA HERPES SIMPLEX IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA HERPES ZOSTER IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA DOCOSANOL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA VALACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA FAMCICLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA PRESCRIPTION DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA OVER-THE COUNTER DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ADULT IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA PEDIATRICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA TOPICAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA ORAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA PARENTERAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA HOSPITALS PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA RETAIL PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA DRUG STORES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA ONLINE PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA HOSPITALS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA SPECIALITY CLINICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 59 U.A.E. HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 60 U.A.E. HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 67 EGYPT HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 68 EGYPT HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 69 EGYPT HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 71 EGYPT HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 72 EGYPT HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 73 EGYPT HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 EGYPT HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 75 ISRAEL HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 76 ISRAEL HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 77 ISRAEL HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 83 REST OF MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA HERPES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA HERPES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA HERPES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA HERPES MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA HERPES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA HERPES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA HERPES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA HERPES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA HERPES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA HERPES MARKET: SEGMENTATION
FIGURE 11 INCREASE IN PREVALENCE OF HERPES INFECTIONS AND RISE IN HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA HERPES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 HERPES SIMPLEX SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA HERPES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA HERPES MARKET
FIGURE 14 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS IN 2020 (IN MILLIONS)
FIGURE 15 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 16 MIDDLE EAST AND AFRICA HERPES MARKET : BY VIRUS TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA HERPES MARKET : BY VIRUS TYPE, 2019-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA HERPES MARKET : BY VIRUS TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA HERPES MARKET : BY VIRUS TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA HERPES MARKET : BY PRODUCT TYPE, 2020
FIGURE 21 MIDDLE EAST AND AFRICA HERPES MARKET : BY PRODUCT TYPE, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA HERPES MARKET : BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA HERPES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA HERPES MARKET : BY DRUG TYPE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA HERPES MARKET : BY DRUG TYPE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA HERPES MARKET : BY DRUG TYPE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA HERPES MARKET : BY DRUG TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA HERPES MARKET: BY AGE, 2020
FIGURE 29 MIDDLE EAST AND AFRICA HERPES MARKET: BY AGE, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA HERPES MARKET: BY AGE, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA HERPES MARKET: BY AGE, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 33 MIDDLE EAST AND AFRICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA HERPES MARKET: DISTRIBUTION CHANNEL, 2020
FIGURE 37 MIDDLE EAST AND AFRICA HERPES MARKET: DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA HERPES MARKET: DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA HERPES MIDDLE EAST AND AFRICA MARKET: DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA HERPES MARKET: BY END USERS, 2020
FIGURE 41 MIDDLE EAST AND AFRICA HERPES MARKET: BYEND USERS, 2019-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA HERPES MARKET: BY END USERS, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA HERPES MARKET: BY END USERS, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA HERPES MARKET: SNAPSHOT (2020)
FIGURE 45 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020)
FIGURE 46 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 MIDDLE EAST AND AFRICA HERPES MARKET: BY VIRUS TYPE (2021-2028)
FIGURE 49 MIDDLE EAST AND AFRICA HERPES MARKET: COMPANY SHARE 2020 (%)
